FDA blood glucose test strip alert not received by 38% of pharmacists in OIG survey.
This article was originally published in The Tan Sheet
Executive Summary
FDA BLOOD GLUCOSE TEST STRIP ALERT MISSED BY 38% OF PHARMACISTS surveyed via phone by HHS' Office of the Inspector General, according to a July 17 OIG report. Examining the effectiveness of an Oct. 11, 1995 FDA safety alert on defective blood glucose test strips manufactured by Diagnostic Solutions, the OIG audit of 462 pharmacies nationwide found that just over 60% of the vendors "acknowledged receiving" the FDA notice.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning